Diabetes :: Japan’s Otsuka to develop saxagliptin for type 2 diabetes

Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced Otsuka has been granted exclusive rights in Japan to develop and commercialize the investigational compound saxagliptin, being studied for the treatment of Type 2 diabetes. Saxagliptin, discovered by Bristol-Myers Squibb, is a dipeptidyl peptidase-4 (DPP-4) inhibitor currently in Phase III development in the United States and Europe.

HIV :: I never claimed I can cure AIDS – Ramdev

Stating that his statement on AIDS was wrongly presented in the media, yoga exponent Baba Ramdev said he will not reply to Health Ministry’s notice. “I never claimed AIDS can be cured through Yoga. It was wrongly been presented in media. I only said cancer can be cured but in case of AIDS one can get encouraging improvement by doing Yoga,” Ramdev told reporters here.

HIV :: New HIV/AIDS vaccine clinical trials

National AIDS Research Institute (NARI), Pune, is conducting a first phase of clinical trial of a newly developed HIV/AIDS vaccine. This ongoing trial is being done under the joint auspices of the National AIDS Control Organization (NACO), the Indian Council of Medical Research (ICMR) and the International AIDS Vaccine Initiative (IAVI).